1. Home
  2. LGVN vs OP Comparison

LGVN vs OP Comparison

Compare LGVN & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • OP
  • Stock Information
  • Founded
  • LGVN 2014
  • OP 2021
  • Country
  • LGVN United States
  • OP Greece
  • Employees
  • LGVN N/A
  • OP N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • OP
  • Sector
  • LGVN Health Care
  • OP
  • Exchange
  • LGVN Nasdaq
  • OP Nasdaq
  • Market Cap
  • LGVN 16.6M
  • OP 14.3M
  • IPO Year
  • LGVN 2021
  • OP N/A
  • Fundamental
  • Price
  • LGVN $0.79
  • OP $1.24
  • Analyst Decision
  • LGVN Strong Buy
  • OP
  • Analyst Count
  • LGVN 2
  • OP 0
  • Target Price
  • LGVN $6.50
  • OP N/A
  • AVG Volume (30 Days)
  • LGVN 496.8K
  • OP 1.2M
  • Earning Date
  • LGVN 11-11-2025
  • OP 12-02-2025
  • Dividend Yield
  • LGVN N/A
  • OP N/A
  • EPS Growth
  • LGVN N/A
  • OP N/A
  • EPS
  • LGVN N/A
  • OP N/A
  • Revenue
  • LGVN $2,073,000.00
  • OP $19,435,000.00
  • Revenue This Year
  • LGVN N/A
  • OP N/A
  • Revenue Next Year
  • LGVN N/A
  • OP N/A
  • P/E Ratio
  • LGVN N/A
  • OP N/A
  • Revenue Growth
  • LGVN 68.67
  • OP N/A
  • 52 Week Low
  • LGVN $0.63
  • OP $1.07
  • 52 Week High
  • LGVN $2.48
  • OP $79.25
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 37.95
  • OP 32.18
  • Support Level
  • LGVN $0.78
  • OP $1.07
  • Resistance Level
  • LGVN $0.85
  • OP $1.21
  • Average True Range (ATR)
  • LGVN 0.05
  • OP 0.12
  • MACD
  • LGVN 0.02
  • OP 0.76
  • Stochastic Oscillator
  • LGVN 46.30
  • OP 25.37

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.

Share on Social Networks: